Associated Papers
Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome.
Tar I et al.
Central-european Journal of Immunology, 2023
Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance.
Asano T et al.
The Journal of Experimental Medicine, 2021
34137790 (PubMed )
Supplement: JEM_20202592_TableS3.xlsx › Table_S2
Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.
de Araujo ED et al.
Cancers, 2019
A Novel STAT3 Mutation in a Qatari Patient With Hyper-IgE Syndrome.
Chaimowitz NS et al.
Frontiers in Pediatrics, 2019
Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome?
de Silva R et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology, 2018
Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome.
Bocchini CE et al.
Blood, 2016
Screening and biological evaluation of a novel STAT3 signaling pathway inhibitor against cancer.
Huang M et al.
Bioorganic & Medicinal Chemistry Letters, 2016
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.
Chandesris MO et al.
Medicine, 2012
Select a paper to view details